Manulife (Manufacturers Life Insurance)
IRON icon

Manulife (Manufacturers Life Insurance)’s Disc Medicine IRON Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.08M Sell
32,493
-20,017
-38% -$1.39M ﹤0.01% 1483
2025
Q4 		$4.07M Buy
52,510
+4,933
+10% +$417K ﹤0.01% 1254
2025
Q3 		$3.14M Sell
47,577
-4,259
-8% -$253K ﹤0.01% 1355
2025
Q2 		$2.75M Buy
51,836
+11,251
+28% +$528K ﹤0.01% 1379
2025
Q1 		$2.01M Buy
40,585
+2,126
+6% +$118K ﹤0.01% 1477
2024
Q4 		$2.44M Buy
38,459
+9,394
+32% +$543K ﹤0.01% 1483
2024
Q3 		$1.43M Buy
29,065
+771
+3% +$36.2K ﹤0.01% 1728
2024
Q2 		$1.28M Buy
28,294
+5,960
+27% +$203K ﹤0.01% 1714
2024
Q1 		$1.39M Buy
22,334
+3,445
+18% +$223K ﹤0.01% 1668
2023
Q4 		$1.09M Buy
18,889
+6,364
+51% +$326K ﹤0.01% 1753
2023
Q3 		$588K Buy
12,525
+5,729
+84% +$287K ﹤0.01% 2053
2023
Q2 		$302K Buy
+6,796
New +$241K ﹤0.01% 2359

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s IRON Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Disc Medicine (IRON) stake by 38% in Q1 2026, selling an estimated $1.39M and leaving 32,493 shares worth $2.08M. The position accounts for ﹤0.01% of the portfolio, ranked #1483.

Manulife (Manufacturers Life Insurance) first reported a position in IRON in Q2 2023 and has held it in 12 quarters since. The position peaked at $4.07M in Q4 2025. 203 funds tracked by Wall St. Rank hold IRON as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 32,493 shares of Disc Medicine worth $2.08M as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 20,017 Disc Medicine shares in Q1 2026, an estimated $1.39M.
  • Disc Medicine made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #1483 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Disc Medicine in Q2 2023 and has held it in 12 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Disc Medicine position peaked at $4.07M in Q4 2025.
  • 203 funds tracked by Wall St. Rank held Disc Medicine as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.